You are viewing the site in preview mode

Skip to main content

Pathologic response rates in HER2-low versus HER2-zero early breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis

Access & Citations

  • 1493
    Article Accesses
  • Data not available
    Web of Science
  • Data not available
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.